Lyssavirus is a group of viruses that cause rabies and rabies-like diseases. The genus contains 18 recognized species, and every single one can trigger a fatal brain infection in humans once symptoms appear. Rabies virus is the most familiar member, but the other 17 species circulate mostly in bat populations across every inhabited continent.
How Lyssaviruses Relate to Rabies
Rabies virus is one species within the broader Lyssavirus genus, which belongs to the Rhabdoviridae family. Think of “lyssavirus” as the umbrella category and “rabies virus” as its most widespread and well-known member. The name comes from “lyssa,” the Greek word for madness or frenzy.
All 18 species produce the same end result in humans: a rapidly progressing, almost universally fatal inflammation of the brain. The case fatality rate approaches 100% once symptoms develop, regardless of which lyssavirus species caused the infection. No treatment currently reverses the disease at the symptomatic stage. This makes lyssaviruses, as a group, among the deadliest pathogens known to infect humans.
The 18 Recognized Species
Scientists organize lyssaviruses into three phylogroups based on how closely related they are genetically. Phylogroup I contains the largest cluster, including rabies virus, Australian bat lyssavirus, European bat lyssavirus 1 and 2, Duvenhage virus, Irkut virus, Aravan virus, Bokeloh bat lyssavirus, Khujand virus, Taiwan bat lyssavirus, and Gannoruwa bat lyssavirus. Phylogroup II includes Lagos bat virus, Mokola virus, and Shimoni bat virus. Three additional species, West Caucasian bat virus, Ikoma lyssavirus, and Lleida bat lyssavirus, fall outside both main groups.
These phylogroup distinctions matter for one practical reason: the standard rabies vaccine works best against phylogroup I viruses, and its effectiveness against phylogroup II and the ungrouped species is less certain.
Bats Are the Primary Reservoir
With the exception of rabies virus itself (which has adapted to dogs, raccoons, skunks, foxes, and other carnivores), virtually every lyssavirus species uses bats as its natural host. Australian bat lyssavirus circulates in two distinct lineages within Australian bat populations, one in fruit bats and another in insectivorous bats. European bat lyssavirus 1 and 2 are found in bats across Europe. Lagos bat virus, Shimoni bat virus, and Duvenhage virus circulate among African bat species. Mokola virus is an unusual outlier: it has been found in shrews and cats in Africa, with no confirmed bat reservoir.
Rabies virus is the exception that dominates headlines. It has successfully jumped into terrestrial carnivore populations worldwide, creating self-sustaining transmission cycles in dogs, which account for the vast majority of the estimated 59,000 human rabies deaths each year. The other lyssaviruses cause far fewer human cases, but confirmed fatalities have been linked to European bat lyssavirus 1, Duvenhage virus, Irkut virus, and Australian bat lyssavirus.
Where Different Lyssaviruses Are Found
Africa has the widest diversity of lyssaviruses, with species from all three phylogroups present on the continent: Duvenhage virus, Lagos bat virus, Mokola virus, Shimoni bat virus, and Ikoma lyssavirus. Europe hosts European bat lyssavirus 1 and 2, Bokeloh bat lyssavirus, Lleida bat lyssavirus (identified in Spain), Kotalahti bat lyssavirus (Finland), and West Caucasian bat virus. Central Asia has Aravan virus (Kyrgyzstan), Khujand virus (Tajikistan), and Irkut virus (Siberia and the Russian Far East). Taiwan bat lyssavirus and Gannoruwa bat lyssavirus (Sri Lanka) are found in Asia.
Australia presents an interesting case. The country is free of classical rabies virus in its wildlife, but Australian bat lyssavirus is well established in bat populations. This means Australians face essentially zero risk from dog bites but a real, if small, risk from contact with sick or injured bats.
How Lyssaviruses Spread
The primary transmission route for all lyssaviruses is a bite from an infected animal. The virus replicates in muscle tissue near the bite, then travels along nerves toward the brain. It also concentrates in saliva, which is how the cycle continues: an infected animal bites another, depositing virus-laden saliva into the wound.
Beyond saliva, lyssavirus can be present in nervous system tissue and tears. Transmission through scratches, open wounds, or mucous membranes that contact infected saliva is possible but less common. Aerosolized transmission has been documented in extremely rare circumstances, such as in bat caves with dense populations, but this is not a realistic risk for most people.
Symptoms and How the Disease Progresses
The incubation period in humans averages one to three months but can range from days to years. The timeline depends largely on where on the body the bite occurred: a bite on the face or hand, closer to the brain and rich in nerve endings, typically leads to faster onset than a bite on the leg.
Early symptoms are vague and easy to dismiss: fever, tingling or pain at the bite site, fatigue, and headache. Within days, the disease shifts into a neurological phase that takes one of two forms. The more common encephalitic (or “furious”) form causes agitation, confusion, hallucinations, and the classic fear of water, called hydrophobia, where the throat spasms painfully when the person tries to swallow. Excessive salivation is another hallmark. The paralytic (or “dumb”) form causes ascending weakness and numbness, resembling conditions like Guillain-Barré syndrome, which can delay diagnosis.
Both forms progress to paralysis, coma, and death, typically within two weeks of symptom onset. Fewer than 20 people have ever survived symptomatic rabies or lyssavirus infection, and most of those survivors had severe neurological impairment.
Vaccine Protection Across Species
Standard rabies vaccines are recommended for post-exposure treatment after any lyssavirus exposure, not just classical rabies. Post-exposure prophylaxis, which combines vaccine doses with a rabies immunoglobulin injection at the wound site, is highly effective at preventing disease when given before symptoms begin. In Australia, for example, the same rabies vaccines approved for classical rabies are specifically indicated for Australian bat lyssavirus exposures.
The catch is that cross-protection varies by phylogroup. Rabies vaccines generate the strongest immune response against phylogroup I lyssaviruses, which share the closest genetic relationship with rabies virus. Protection against phylogroup II species (Lagos bat virus, Mokola virus, Shimoni bat virus) and the ungrouped viruses is less well established, though the vaccines are still recommended because no better alternative exists. Animal studies and limited clinical experience support their use across species.
Pre-exposure vaccination is recommended for people at higher risk: wildlife researchers, bat handlers, veterinarians working with potentially exposed animals, and travelers heading to areas where rabies is common and medical care is remote. Pre-exposure vaccination does not eliminate the need for additional doses after an actual exposure, but it simplifies the treatment protocol and buys critical time.
Why Non-Rabies Lyssaviruses Matter
Human deaths from non-rabies lyssaviruses are rare, but they carry an outsized significance. A fatal case of Irkut virus was confirmed in the Russian Far East after a bat bite, and lethal encephalitis from European bat lyssavirus 1 has been documented in Western Europe. These cases demonstrate that any bat contact in any part of the world carries potential lyssavirus risk, even in countries that have eliminated classical rabies.
The practical takeaway is straightforward. Any bat bite or scratch, or any situation where a bat may have had contact with broken skin or mucous membranes (including waking up to find a bat in your room), warrants prompt medical evaluation for post-exposure treatment. The window between exposure and symptom onset is the only window in which the disease can be prevented.